Welcome to our dedicated page for Ultralife Corporation news (Ticker: ULBI), a resource for investors and traders seeking the latest updates and insights on Ultralife Corporation stock.
Ultralife Corporation (symbol: ULBI) is a global company that started as a battery manufacturer and has since diversified its offerings to include a wide range of portable and standby power solutions, as well as communications and electronics systems. Established in 1990 and publicly traded since 1992, Ultralife operates through two main segments: Battery and Energy Products and Communications Systems.
The Battery and Energy Products segment is the primary revenue generator and offers a comprehensive range of rechargeable and non-rechargeable batteries, chargers, and accessories. These products serve various markets, including commercial, medical, and military sectors. The product lineup includes lithium 9-volt batteries, cylindrical batteries, and other non-rechargeable battery types.
In the Communications Systems segment, Ultralife provides power and amplification solutions that complement numerous commercial and military portable radios and communication systems. This suite of products is critical for ensuring reliable performance in demanding environments.
Ultralife’s family of brands includes Ultralife Batteries, Able, McDowell Research, AMTI, and Accutronics Ltd, with operational footprints spanning North America, Europe, and Asia. This extensive brand portfolio and global presence enable Ultralife to reach diverse markets and meet various customer needs.
Recent achievements include the expansion of their LinkedIn showcase pages dedicated to their battery & energy solutions and communication systems. These platforms provide the latest updates and developments, ensuring stakeholders stay informed about new products, financial performance, and other significant company news.
Ultralife Corporation continues to innovate and adapt to the changing demands of its diverse customer base. By focusing on quality, reliability, and innovation, the company maintains its reputation as a trusted provider of power and communication solutions globally.
Ultralife Corporation (NASDAQ: ULBI) has secured a firm-fixed price contract from the U.S. Army for Conformal Wearable Batteries, valued at up to $168 million over three years. The contract may extend to an additional $350 million based on one-year options. This award is part of a $1.25 billion program aimed at enhancing soldier mobility with lightweight batteries that sustain operations for up to 24 hours. Ultralife's selection underscores its reputation for reliability and safety in military applications.
Ultralife Corporation (NASDAQ: ULBI) reported a slight increase in revenue to $26.0 million for Q1 2021, up 0.6% year-over-year. Operating income fell to $1.0 million, down from $1.5 million in the same quarter last year. The company saw a 32% increase in medical device battery sales and 30% growth in government/defense sales, but these were offset by a 30% decline in oil & gas market sales and a 23.6% decrease in Communications Systems sales. Net income was $0.7 million or $0.04 per diluted share, reflecting $2.0 million adverse impact from COVID-19.
Ultralife Corporation (NASDAQ: ULBI) is set to announce its first quarter results for the period ending March 31, 2021, before the market opens on April 29, 2021. The management will follow with an investor conference call at 8:30 AM ET the same day. Interested participants can join the call by dialing (800) 915-4836. A live webcast will also be available on the company's website, with a replay accessible shortly after the call. Ultralife offers a range of products and services in power solutions and communication systems globally.
Ultralife Corporation (NASDAQ: ULBI) reported mixed Q4 2020 results with revenue of $29.0 million, down 6.6% from $31.0 million in Q4 2019. GAAP EPS increased to $0.13 from $0.10, while Adjusted EPS rose to $0.17 from $0.13. Operating income dropped to $1.2 million from $2.5 million amid a $2.6 million negative impact from COVID-19. Medical battery sales surged 94%, but oil & gas market sales fell 67.4%. The company's debt was reduced by 91.5% to $1.5 million, and cash-on-hand grew 43.9% to $10.7 million, highlighting resilience amidst challenges.
Ultralife Corporation (NASDAQ: ULBI) is set to report its fourth quarter results for the fiscal year ending December 31, 2020, on February 4, 2021, before the market opens. Management will host an investor conference call at 8:30 AM ET on the same day, accessible via phone or a live webcast. The call aims to engage with investors, providing an overview of the company’s performance. Ultralife specializes in power solutions and communications systems, serving government, defense, and commercial sectors globally.
Ultralife Corporation (NASDAQ: ULBI) reported a third-quarter operating income of $0.7 million on revenue of $24.4 million for the period ending September 30, 2020. Revenue decreased by 11.4% from $27.5 million last year, with operating income down from $1.3 million. Medical sales surged 102%, but were countered by weak oil & gas market performance and a 48.3% decline in Communications Systems sales. Despite challenges from COVID-19, the company reduced debt by $7.1 million and increased cash reserves by $5.4 million, asserting a solid balance sheet amid ongoing economic pressures.
Ultralife Corporation (NASDAQ: ULBI) is set to release its third quarter financial results for the period ending September 30, 2020, on October 29, 2020, before market opening. Management will hold an investor conference call and webcast at 8:30 AM ET on the same day. Participants can join the call by dialing (800) 915-4836 and a replay will be available shortly after. Ultralife specializes in power solutions and communication systems for government, defense, and commercial customers globally, with operations across North America, Europe, and Asia.
Ultralife Corporation (NASDAQ: ULBI) reported operating income of $2.3 million and revenue of $28.6 million for Q2 2020, down from $3.0 million and $29.4 million in Q2 2019. The company saw a 72% increase in medical battery sales and a 50% rise in government/defense sales, though overall revenue faced a 2.8% decline. Gross profit was $8 million, representing 27.9% of revenue. Adjusted EPS decreased to $0.13 from $0.18 year-over-year, while Adjusted EBITDA was $3.3 million. Ultralife aims to maintain profitability and liquidity amid economic challenges.
Ultralife Corporation (NASDAQ: ULBI) will announce its second quarter results for the period ending June 30, 2020, before the market opens on July 30, 2020. A conference call will follow on the same day at 8:30 AM ET, where management will discuss the results. Investors can join the call by dialing (800) 915-4836 or via a live webcast available on the company's website. For those unable to attend live, a replay will be accessible shortly after the call. Ultralife provides power solutions and communication systems globally to government, defense, and commercial sectors.
Ultralife Corporation (NASDAQ: ULBI) announced a change in the location of its Annual Meeting of Shareholders due to the COVID-19 pandemic. The meeting will now take place on July 22, 2020, at the company's headquarters in Newark, NY, instead of The Westin Crystal City in Arlington, VA. All other details remain unchanged. Shareholders eligible to vote are those on record as of May 26, 2020. For more information regarding voting procedures, shareholders are directed to the proxy materials filed with the SEC and available on the company's website.
FAQ
What is the current stock price of Ultralife Corporation (ULBI)?
What is the market cap of Ultralife Corporation (ULBI)?
What does Ultralife Corporation do?
When was Ultralife Corporation founded?
What are the main segments of Ultralife Corporation?
What products are offered by the Battery and Energy Products segment?
Where does Ultralife Corporation operate?
Which brands are part of Ultralife Corporation?
How does Ultralife Corporation keep stakeholders informed?
Who are the primary customers of Ultralife Corporation?
What recent achievements has Ultralife Corporation made?
How does Ultralife Corporation ensure product reliability?
